Case Report: Triple Negative Ulcerated Breast Cancer with Immunosuppressive Cold Tumor Environment
Main Article Content
Abstract
Breast cancer is the most common malignancy among women worldwide according to Global Cancer Observatory (GLOBOCAN) data. One aggressive clinical form is ulcerative breast cancer, which is often categorized as locally advanced breast cancer (LABC). We report a case of a 42-year-old woman presenting with a left breast mass for 7 months that progressively developed into an ulcer with brownish, tea-colored discharge, without pain in the early phase and without systemic symptoms. Physical examination revealed an ulcerative mass with irregular margins, granulation tissue, and superficial collateral veins. Histopathological findings from FNAB and incisional biopsy confirmed invasive breast carcinoma of no special type (NST), WHO grade 3, with lymphovascular space invasion (LVSI+). Radiological evaluation showed no distant metastasis. The absence of pain and systemic inflammation in this case may be associated with the predominance of immunosuppressive cytokines such as IL-10 and TGF-β, which suppress nociceptor activation and systemic inflammatory responses, despite ongoing local inflammation. Management was carried out using a multimodal approach including supportive therapy, antibiotics, and planned mastectomy as definitive treatment. This case highlights the importance of clinical vigilance, as ulcerative breast cancer may progress without significant systemic symptoms.
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Abdelhafiz, A. S., Fouda, M. A., Elzefzafy, N. A., Taha, I. I., Mohemmed, O. M., Alieldin, N. H., ... & Farahat, I. G. (2021). Gene expression analysis of invasive breast carcinoma yields differential patterns in luminal subtypes of breast cancer. Annals of Diagnostic Pathology, 55, 151814. https://doi.org/10.1016/j.anndiagpath.2021.151814
Adhyatma, A. A., & Nurlela, S. (2021). The Relationship of Family Support with The Practice of Breast Examination (Breast Examination) an Adolescent Women at High School 17 Batam, Batam City, Riau Islands Province, 2021. Jurnal Ilmiah Ilmu Keperawatan Indonesia, 11(01). https://doi.org/10.33221/jiiki.v11i01.2096
Alitalo, A., & Detmar, M. (2012). Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene, 31(42), 4499-4508.
Asselain, B., Barlow, W., Bartlett, J., Bergh, J., Bergsten-Nordström, E., Bliss, J., ... & Zujewski, J. A. (2018). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19(1), 27-39.
Banerjee, K., Kakkar, A., Shamsi, K. A., Bansal, D., Mathur, P., Potode, N. M., ... & Joglekar, S. (2024). Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India. Drugs-Real World Outcomes, 11(1), 53-68. https://doi.org/10.1007/s40801-023-00406-x
Birgin, E., Yang, C., Hetjens, S., Reissfelder, C., Hohenberger, P., & Rahbari, N. N. (2020). Core needle biopsy versus incisional biopsy for differentiation of soft‐tissue sarcomas: a systematic review and meta‐analysis. Cancer, 126(9), 1917-1928. https://doi.org/10.1002/cncr.32735
Brnić, S., Špiljak, B., Zanze, L., Barac, E., Likić, R., & Lugović-Mihić, L. (2025). Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review. Biomedicines, 13(8), 1901. https://doi.org/10.3390/biomedicines13081901
Buchholz, T. A., Hunt, K. K., Whitman, G. J., Sahin, A. A., & Hortobagyi, G. N. (2003). Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer: Interdisciplinary International Journal of the American Cancer Society, 98(6), 1150-1160. https://doi.org/10.1002/cncr.11603
Cejalvo, J. M., Pascual, T., Fernández-Martínez, A., Brasó-Maristany, F., Gomis, R. R., Perou, C. M., ... & Prat, A. (2018). Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer. Cancer treatment reviews, 67, 63-70. https://doi.org/10.1016/j.ctrv.2018.04.015
Chabner, B. A., & Longo, D. L. (2015). Manual de oncologia de Harrison. Amgh Editora.
Cheng, Y. C., & Ueno, N. T. (2012). Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast cancer, 19(3), 191-199. https://doi.org/10.1007/s12282-011-0276-3
Chow, R., Simone, C. B., & Rimner, A. (2024). Management of malignant superior vena cava syndrome. Annals of Palliative Medicine, 13(3), 620-626.
Ciurescu, S., Buciu, V., Șerban, D., Borozan, F., Tomescu, L., Cobec, I. M., ... & Sas, I. (2025). Role of cytokines in breast cancer: a systematic review and meta-analysis. Biomedicines, 13(9), 2203. https://doi.org/10.3390/biomedicines13092203
Decker, M. R., Greenblatt, D. Y., Havlena, J., Wilke, L. G., Greenberg, C. C., & Neuman, H. B. (2012). Impact of neoadjuvant chemotherapy on wound complications after breast surgery. Surgery, 152(3), 382-388. https://doi.org/10.1016/j.surg.2012.05.001
Di Bacco, A., Keeshan, K., McKenna, S. L., & Cotter, T. G. (2000). Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. The oncologist, 5(5), 405-415. https://doi.org/10.1634/theoncologist.5-5-405
Firmino, F., Villela-Castro, D. L., Dos Santos, J., & de Gouveia Santos, V. L. C. (2021). Topical management of bleeding from malignant wounds caused by breast cancer: a systematic review. Journal of Pain and Symptom Management, 61(6), 1278-1286. https://doi.org/10.1016/j.jpainsymman.2020.10.020
Guerrini, R., & Dobyns, W. B. (2014). Malformations of cortical development: clinical features and genetic causes. The Lancet Neurology, 13(7), 710-726.
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023). Crosstalk of inflammatory cytokines within the breast tumor microenvironment. International journal of molecular sciences, 24(4), 4002. https://doi.org/10.3390/ijms24044002
Hashmi, A. A., Mahboob, R., Khan, S. M., Irfan, M., Nisar, M., Iftikhar, N., ... & Edhi, M. M. (2018). Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers. BMC Research Notes, 11(1), 574. https://doi.org/10.1186/s13104-018-3677-y
Hassanpour, S. H., & Dehghani, M. (2017). Review of cancer from perspective of molecular. Journal of cancer research and practice, 4(4), 127-129. https://doi.org/10.1016/j.jcrpr.2017.07.001
Iffland, P. H., & Crino, P. B. (2017). Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications. Annual Review of Pathology: Mechanisms of Disease, 12, 547-571. https://doi.org/10.1146/annurev-pathol-052016-100138
Imani, S., Farghadani, R., Roozitalab, G., Maghsoudloo, M., Emadi, M., Moradi, A., ... & Jabbarzadeh Kaboli, P. (2025). Reprogramming the breast tumor immune microenvironment: cold-to-hot transition for enhanced immunotherapy. Journal of Experimental & Clinical Cancer Research, 44(1), 131.
Islamyati, N., & Suryati, S. (2023). Overview Of Knowledge Of Women Of Fertilizing Age About Being Conscious In Sampungu Village, Soromandi District, Bima District, 2023. Jurnal EduHealth, 14(04), 497-503.
Karaman, S., & Detmar, M. (2014). Mechanisms of lymphatic metastasis. The Journal of clinical investigation, 124(3), 922-928.
Kerr, D. J., Haller, D. G., van de Velde, C. J., & Baumann, M. (Eds.). (2016). Oxford textbook of oncology. oxford university press.
Kimbung, S., Kovács, A., Danielsson, A., Bendahl, P. O., Lövgren, K., Stolt, M. F., ... & Hedenfalk, I. (2015). Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications. Oncotarget, 6(32), 33306. https://doi.org/10.18632/oncotarget.5089
King, T. A., & Morrow, M. (2015). Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nature reviews Clinical oncology, 12(6), 335-343. https://doi.org/10.1200/JCO.2003.05.208
Klein, C. A. (2020). Cancer progression and the invisible phase of metastatic colonization. Nature Reviews Cancer, 20(11), 681-694.
Leber, M. F., & Efferth, T. (2009). Molecular principles of cancer invasion and metastasis. International journal of oncology, 34(4), 881-895. https://doi.org/10.3892/ijo_00000214
Lv, X., & Ding, S. (2025). Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities. Frontiers in endocrinology, 16, 1608612. https://doi.org/10.3389/fendo.2025.1608612
Ma, W., Meng, W., Yin, J., Liang, J., Wang, X., Liu, J., & Shi, F. (2025). Predictive value of models based on MRI radiomics and clinical indicators for lymphovascular space invasion in endometrial cancer. BMC cancer, 25(1), 796. https://doi.org/10.1186/s12885-025-14217-6
Macaron, W., Sargsyan, Z., & Short, N. J. (2022). Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leukemia & Lymphoma, 63(8), 1780-1791. https://doi.org/10.1080/10428194.2022.2056178
Magro, F., Langner, C., Driessen, A., Ensari, A. R. Z. U., Geboes, K., Mantzaris, G. J., ... & European Society of Pathology (ESP) and the European Crohn's and Colitis Organisation (ECCO). (2013). European consensus on the histopathology of inflammatory bowel disease. Journal of Crohn's and Colitis, 7(10), 827-851. https://doi.org/10.1016/j.crohns.2013.06.001
Manka, W., Solowiow, R., & Okrzeja, D. (2000). Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil. Drug safety, 22(1), 83-88. https://doi.org/10.2165/00002018-200022010-00007
Milam, E. C., Rangel, L. K., & Pomeranz, M. K. (2021). Dermatologic sequelae of breast cancer: From disease, surgery, and radiation. International Journal of Dermatology, 60(4), 394-406. https://doi.org/10.1111/ijd.15303
Mumprecht, V., & Detmar, M. (2009). Lymphangiogenesis and cancer metastasis. Journal of cellular and molecular medicine, 13(8a), 1405-1416. https://doi.org/10.1111/j.1582-4934.2009.00834.x
Niklinski, J., Niklinska, W., Chyczewski, L., Becker, H. D., & Pluygers, E. (2001). Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. European journal of cancer prevention, 10(3), 213-226.
O’Halloran, N., Lowery, A., Curran, C., McLaughlin, R., Malone, C., Sweeney, K., ... & Kerin, M. (2019). A review of the impact of neoadjuvant chemotherapy on breast surgery practice and outcomes. Clinical Breast Cancer, 19(5), 377-382. https://doi.org/10.1016/j.clbc.2019.04.011
Pan, L., Li, J., Xu, Q., Gao, Z., Yang, M., Wu, X., & Li, X. (2024). HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review. Medicine, 103(24), e38508.
Pengsin, N. A. H., & Meyasa, O. (2025). Determinants of Breast Self-Examination Practices Among Female Vocational High School Students. SIGn Journal of Public Health, 4(1), 40-54. https://doi.org/10.37276/sjph.v4i1.679
Rao, R. S., Chatura, K. R., Prasad, K., Lakshminarayana, S., Ali, F. M., Awan, K. H., & Patil, S. (2020). Procedures and pitfalls in incisional biopsies of oral squamous cell carcinoma with respect to histopathological diagnosis. Disease-a-month, 66(12), 101035.
Rašková, M., Lacina, L., Kejík, Z., Venhauerová, A., Skaličková, M., Kolář, M., ... & Brábek, J. (2022). The role of IL-6 in cancer cell invasiveness and metastasis—overview and therapeutic opportunities. Cells, 11(22), 3698. https://doi.org/10.3390/cells11223698
Rastogi, A. (2018). Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World journal of gastroenterology, 24(35), 4000. https://doi.org/10.3748/wjg.v24.i35.4000
Redig, A. J., & McAllister, S. S. (2013). Breast cancer as a systemic disease: a view of metastasis. Journal of internal medicine, 274(2), 113-126. https://doi.org/10.1111/joim.12084
Ring, A., Webb, A., Ashley, S., Allum, W. H., Ebbs, S., Gui, G., ... & Smith, I. E. (2003). Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer?. Journal of clinical oncology, 21(24), 4540-4545.
Sundaram, G. M., Quah, S., & Sampath, P. (2018). Cancer: the dark side of wound healing. The FEBS journal, 285(24), 4516-4534. https://doi.org/10.1111/febs.14586
Velayutham, D., Elango, R., Rashid, S., Al-Sarraf, R., Akhtar, M., Ouararhni, K., ... & Alajez, N. M. (2025). Somatic Mutation Profiling and Therapeutic Landscape of Breast Cancer in the MENA Region. Cells, 14(22), 1791. https://doi.org/10.3390/cells14221791
Wang, J., & Wu, S. G. (2023). Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives. Breast Cancer: Targets and Therapy, 721-730.
Zotova, N., Zhuravleva, Y., Chereshnev, V., & Gusev, E. (2023). Acute and chronic systemic inflammation: features and differences in the pathogenesis, and integral criteria for verification and differentiation. International journal of molecular sciences, 24(2), 1144. https://doi.org/10.3390/ijms24021144